300972 Stock Overview
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 6/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Fujian Wanchen Biotechnology Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥20.32 |
52 Week High | CN¥41.90 |
52 Week Low | CN¥17.69 |
Beta | -0.016 |
11 Month Change | -4.24% |
3 Month Change | -30.55% |
1 Year Change | -47.63% |
33 Year Change | 30.84% |
5 Year Change | n/a |
Change since IPO | -25.57% |
Recent News & Updates
We Think Fujian Wanchen Biotechnology Group (SZSE:300972) Is Taking Some Risk With Its Debt
Aug 04Sentiment Still Eluding Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972)
Jun 06Shareholder Returns
300972 | CN Food | CN Market | |
---|---|---|---|
7D | 11.3% | 1.7% | 0.8% |
1Y | -47.6% | -22.9% | -21.0% |
Return vs Industry: 300972 underperformed the CN Food industry which returned -22.9% over the past year.
Return vs Market: 300972 underperformed the CN Market which returned -21% over the past year.
Price Volatility
300972 volatility | |
---|---|
300972 Average Weekly Movement | 6.4% |
Food Industry Average Movement | 5.0% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 300972's share price has been volatile over the past 3 months.
Volatility Over Time: 300972's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 4,972 | Li Qing Wang | www.vanchen.com |
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.
Fujian Wanchen Biotechnology Group Co., Ltd. Fundamentals Summary
300972 fundamental statistics | |
---|---|
Market cap | CN¥3.60b |
Earnings (TTM) | -CN¥129.32m |
Revenue (TTM) | CN¥13.36b |
0.3x
P/S Ratio-27.8x
P/E RatioIs 300972 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300972 income statement (TTM) | |
---|---|
Revenue | CN¥13.36b |
Cost of Revenue | CN¥12.15b |
Gross Profit | CN¥1.21b |
Other Expenses | CN¥1.34b |
Earnings | -CN¥129.32m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 27, 2024
Earnings per share (EPS) | -0.73 |
Gross Margin | 9.04% |
Net Profit Margin | -0.97% |
Debt/Equity Ratio | 95.9% |
How did 300972 perform over the long term?
See historical performance and comparison